Вы искали: breastfeed (Английский - Мальтийский)

do not breastfeed while taking xaluprine.
treddax waqt li tkun qiegħda tieħu xaluprine.

women receiving myocet should not breastfeed.
nisa li jkunu fuq myocet m’għandhomx ireddgħu.

you must not breastfeed during treatment with javlor
m’għandekx tredda’ waqt il-kura bil-javlor.

do not breastfeed while you are taking opsumit.
treddax waqt li tkun qed tieħu opsumit.

if you want to breastfeed talk to your doctor first.
jekk trid tredda’, l-ewwel kellem lit-tabib tiegħek.

women should not breastfeed during treatment with raptiva.
in-nisa ma jistgħawx jreddgħu waqt il-kura ma’ raptiva.

therefore, you should not breastfeed when using this medicine.
għaldaqstant, m’għandekx tredda’ meta tuża din il-mediċina.

mothers should be instructed not to breastfeed if they are taking daklinza.
l-ommijiet għandhom jingħataw istruzzjonijiet biex ma jreddgħux jekk ikunu qed jieħdu daklinza.

therefore it is not recommended to breastfeed whilst being treated with atryn.
ghalhekk, mhux rakkomandat li mara tredda 'waqt li tkun qed tigi kkurata b' atryn.

if you want to breastfeed while using plegridy, talk to your doctor first.
jekk tixtieq tredda’ waqt li tkun qed tuża plegridy, kellem lit-tabib tiegħek l-ewwel.

that the patient should not breastfeed during treatment and for 20 months after their final dose
li l-pazjenta m’għandhiex tredda’ waqt it-trattament u għal mill-inqas 20 xhur wara l-aħħar doża tagħha

you should not use adenuric if you are breast feeding, or if you are planning to breastfeed.
m’għandek tuża adenuric jekk qed tredda’, jew jekk qed tippjana li tredda’.

do not breastfeed when taking thalidomide celgene as it is not known if thalidomide is passed into human breast milk.
treddax waqt li tkun qed tieħu thalidomide celgene għax mhux magħruf jekk thalidomide jgħaddix fil-ħalib tas-sider uman.

women should not breastfeed while treated with orencia and for up to 14 weeks after the last dose of abatacept treatment.
nisa m’għandhomx ireddgħu waqt trattament b’orencia u għal 14-il ġimgħa wara l-aħħar doża ta’ trattament b’abatacept.

in addition, vaccine immunogenicity was comparable among breastfeeding mothers and women who did not breastfeed during the vaccine administration.
flimkien ma' dan, l-immunoġeniċità tal-vaċċin kienet komparabbli fost l-ommijiet li kienu jreddgħu u n-nisa li ma kienux qed ireddgħu waqt l-għoti tal- vaċċin.

propranolol passes through breast milk, mothers being treated with propranolol who breastfeed their infant should inform their health care professional.
il-propranolol jgħaddi permezz tal-ħalib tas-sider, l-ommijiet li qed jiġu kkurati bil-propranolol li qed ireddgħu it-tarbija tagħhom għandhom jinfurmaw il-professjonist tal-kura tas-saħħa tagħhom.

as a general rule, it is recommended that mothers infected by hiv do not breastfeed their babies under any circumstances in order to avoid transmission of hiv.
bħala regola ġenerali, huwa rakkomandat li ommijiet infettati bl-hiv m’għandhomx irreddgħu t-trabi tagħhom taħt l-ebda ċirkustanza sabiex jevvitaw it-trażmissjoni ta’ l-hiv.

in addition, vaccine immunogenicity was comparable among breast-feeding mothers and women who did not breastfeed during the vaccine administration.
flimkien ma' dan, l-immunoġeniċità tal-vaċċin kienet komparabbli fost l-ommijiet li kienu jreddgħu u n-nisa li ma kienux qed ireddgħu waqt l-għoti tal-vaċċin.

because a potential risk to the breast-feeding infant cannot be ruled out , it is recommended that women should not breastfeed during treatment with deltyba.
minħabba li riskju potenzjali għat-tarbija li qed titredda’ ma jistax jiġi eskluż, hu rakkomandat li nisa m’għandhomx ireddgħu waqt it-trattament b’ deltyba.

it is unknown whether icatibant is excreted in human breast milk but it is recommended that breastfeeding women, who wish to take firazyr, should not breastfeed for 12 hours after treatment.
mhux magħruf jekk icatibant jitneħħiex fil-ħalib tas-sider uman iżda huwa rakkomandat li nisa jreddgħu li jkunu jixtiequ jieħdu firazyr, m’għandhomx ireddgħu għal 12-il siegħa wara t-trattament.